tiprankstipranks
Advertisement
Advertisement
Is MGNX a Buy, Before Earnings?
PremiumPre-EarningsIs MGNX a Buy, Before Earnings?
6d ago
MacroGenics Expands ZYNYZ Royalty Agreement for Added Funding
Premium
Company Announcements
MacroGenics Expands ZYNYZ Royalty Agreement for Added Funding
13d ago
MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement
Premium
The Fly
MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement
13d ago
MacroGenics Resumes LINNET Trial After FDA Hold Lifted
PremiumCompany AnnouncementsMacroGenics Resumes LINNET Trial After FDA Hold Lifted
1M ago
MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study
Premium
The Fly
MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study
1M ago
MacroGenics price target raised to $4 from $3 at Barclays
Premium
The Fly
MacroGenics price target raised to $4 from $3 at Barclays
2M ago
MacroGenics, Inc. Reports Decline in Quarterly Revenues
PremiumCompany AnnouncementsMacroGenics, Inc. Reports Decline in Quarterly Revenues
6M ago
Strategic Shift and Transitional Phases Lead to Hold Rating for MacroGenics
Premium
Ratings
Strategic Shift and Transitional Phases Lead to Hold Rating for MacroGenics
6M ago
MacroGenics reports Q3 EPS 27c vs 90c last year
Premium
The Fly
MacroGenics reports Q3 EPS 27c vs 90c last year
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100